Ltd .) in PBS containing 0. 05% Tween 20 ( PBS - T ), the membranes were incubated with the appropriate primary antibodies ( anti - GAPDH ( Millipore, 1: 1000 ), anti - Bax ( cell signaling, 1: 1000 ), anti - Bcl - 2 ( cell signaling, 1: 1000 ), anti - phospho - JNK ( p - JNK, Cell Signaling, 1: 1000 ), anti - phospho - p38MAPK ( p - p38MAPK, cell signaling, 1: 1000 ), anti - myelin basic protein ( MBP, Santa cruz, 1: 1000 ), anti - oligodendrocyte transcription factor 1 ( Olig1, Rockland, 1: 1000 ), anti - glial fibrillary acidic protein ( GFAP, Epitomics, 1: 1000 ), anti - glutamine synthetase ( GS, Abcam, 1: 1000 )) overnight, followed by incubation with horseradish peroxidase - conjugated secondary antibodies for 2 h at room temperature.	"Tween 20	32	40	Chemical/Drug"	"GAPDH	132	137	Gene/Protein"	"Bax	169	172	Gene/Protein"	"Bcl - 2	209	216	Gene/Protein"	"JNK	263	266	Gene/Protein"	"JNK	273	276	Gene/Protein"	"p38MAPK	322	329	Gene/Protein"	"p38MAPK	336	343	Gene/Protein"	"myelin basic protein	379	399	Gene/Protein"	"MBP	402	405	Gene/Protein"	"oligodendrocyte transcription factor 1	437	475	Gene/Protein"	"Olig1	478	483	Gene/Protein"	"glial fibrillary acidic protein	513	544	Gene/Protein"	"GFAP	547	551	Gene/Protein"	"glutamine synthetase	582	602	Gene/Protein"	"GS	605	607	Gene/Protein"	"horseradish	666	677	Organism/Species"	"peroxidase	678	688	Gene/Protein"	"[{""token"": ""Tween 20"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""GAPDH"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Bax"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""p38MAPK"", ""start_span"": 322, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""p38MAPK"", ""start_span"": 336, ""end_span"": 343, ""type"": ""Gene/Protein""}, {""token"": ""myelin basic protein"", ""start_span"": 379, ""end_span"": 399, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 402, ""end_span"": 405, ""type"": ""Gene/Protein""}, {""token"": ""oligodendrocyte transcription factor 1"", ""start_span"": 437, ""end_span"": 475, ""type"": ""Gene/Protein""}, {""token"": ""Olig1"", ""start_span"": 478, ""end_span"": 483, ""type"": ""Gene/Protein""}, {""token"": ""glial fibrillary acidic protein"", ""start_span"": 513, ""end_span"": 544, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 547, ""end_span"": 551, ""type"": ""Gene/Protein""}, {""token"": ""glutamine synthetase"", ""start_span"": 582, ""end_span"": 602, ""type"": ""Gene/Protein""}, {""token"": ""GS"", ""start_span"": 605, ""end_span"": 607, ""type"": ""Gene/Protein""}, {""token"": ""horseradish"", ""start_span"": 666, ""end_span"": 677, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 678, ""end_span"": 688, ""type"": ""Gene/Protein""}]"
Assay were performed after 24 h of in vitro culture. a Change of H3K9 acetylation on the promoter of Sox9. b Change of H3K14 acetylation on the promoter of Sox9. c Change of NFATc2 binding on the promoter of Sox9. d Change of 1 binding on the promoter of Sox9. e Change of Sox9 binding on the enhancer of Col2A1. f Effects of methyllycaconitine ( MLA) and Si - NFATc2 on nicotine ’ s suppression of H3K9 acetylation on the promoter of Sox9. g Effects of MLA and Si - NFATc2 on nicotine ’ s suppression of H3K14 acetylation on the promoter of Sox9. h Effects of MLA and Si - NFATc2 on nicotine ’ s suppression of Sox9 binding on the enhancer of Col2A1.	"Sox9	101	105	Gene/Protein"	"Sox9	156	160	Gene/Protein"	"NFATc2	174	180	Gene/Protein"	"Sox9	208	212	Gene/Protein"	"Sox9	255	259	Gene/Protein"	"Sox9	273	277	Gene/Protein"	"Col2A1	305	311	Gene/Protein"	"methyllycaconitine	326	344	Chemical/Drug"	"NFATc2	361	367	Gene/Protein"	"nicotine	371	379	Chemical/Drug"	"Sox9	435	439	Gene/Protein"	"NFATc2	467	473	Gene/Protein"	"nicotine	477	485	Chemical/Drug"	"Sox9	542	546	Gene/Protein"	"NFATc2	574	580	Gene/Protein"	"nicotine	584	592	Chemical/Drug"	"Sox9	612	616	Gene/Protein"	"Col2A1	644	650	Gene/Protein"	"[{""token"": ""Sox9"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 305, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""methyllycaconitine"", ""start_span"": 326, ""end_span"": 344, ""type"": ""Chemical/Drug""}, {""token"": ""NFATc2"", ""start_span"": 361, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 371, ""end_span"": 379, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 435, ""end_span"": 439, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 467, ""end_span"": 473, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 477, ""end_span"": 485, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 542, ""end_span"": 546, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 574, ""end_span"": 580, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 584, ""end_span"": 592, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 612, ""end_span"": 616, ""type"": ""Gene/Protein""}, {""token"": ""Col2A1"", ""start_span"": 644, ""end_span"": 650, ""type"": ""Gene/Protein""}]"
The rate - limiting enzyme that metabolizes tryptophan to kynurenine, indoleamine 2, 3 - dioxygenase ( IDO, Figure 1 ), is potently upregulated by pro - inflammatory cytokines. 12 Inflammation - associated depression scores in human patients are associated with an elevated kynurenine / tryptophan ratio, an indicator of IDO activity, 13 and numerous preclinical mouse models have established IDO - dependent kynurenine metabolism as an important mediator of inflammation - induced depressive - like behaviors. 14, 15, 16, 17, 18 Interestingly, microglia are the predominant cells expressing the enzyme ( kynurenine 3 - monooxygenase, KMO, Figure 1) for the generation of neurotoxic kynurenine metabolites, and reports in both human19 and in mice20 have implicated microglial - derived21, 22 downstream neurotoxic kynurenine metabolites in the pathogenesis of inflammation - associated depression; however, mechanistic studies are yet to be performed.	"tryptophan	44	54	Chemical/Drug"	"kynurenine	58	68	Chemical/Drug"	"IDO	103	106	Gene/Protein"	"pro - inflammatory cytokines	147	175	Gene/Protein"	"depression	206	216	Disease/Disorder"	"human	227	232	Organism/Species"	"kynurenine	274	284	Chemical/Drug"	"tryptophan	287	297	Chemical/Drug"	"IDO	321	324	Gene/Protein"	"mouse	363	368	Organism/Species"	"IDO	393	396	Gene/Protein"	"kynurenine	409	419	Chemical/Drug"	"kynurenine 3 - monooxygenase	605	633	Gene/Protein"	"KMO	635	638	Gene/Protein"	"kynurenine	683	693	Chemical/Drug"	"human19	727	734	Organism/Species"	"kynurenine	814	824	Chemical/Drug"	"depression	886	896	Disease/Disorder"	"[{""token"": ""tryptophan"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""IDO"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""pro - inflammatory cytokines"", ""start_span"": 147, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""depression"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""kynurenine"", ""start_span"": 274, ""end_span"": 284, ""type"": ""Chemical/Drug""}, {""token"": ""tryptophan"", ""start_span"": 287, ""end_span"": 297, ""type"": ""Chemical/Drug""}, {""token"": ""IDO"", ""start_span"": 321, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 363, ""end_span"": 368, ""type"": ""Organism/Species""}, {""token"": ""IDO"", ""start_span"": 393, ""end_span"": 396, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 409, ""end_span"": 419, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine 3 - monooxygenase"", ""start_span"": 605, ""end_span"": 633, ""type"": ""Gene/Protein""}, {""token"": ""KMO"", ""start_span"": 635, ""end_span"": 638, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 683, ""end_span"": 693, ""type"": ""Chemical/Drug""}, {""token"": ""human19"", ""start_span"": 727, ""end_span"": 734, ""type"": ""Organism/Species""}, {""token"": ""kynurenine"", ""start_span"": 814, ""end_span"": 824, ""type"": ""Chemical/Drug""}, {""token"": ""depression"", ""start_span"": 886, ""end_span"": 896, ""type"": ""Disease/Disorder""}]"
Effect sizes for the associations are as follows: ( C) 0. 69 - fold - change in integrated HIV DNA for 1 point increase in percentage of PD - 1 / TIGIT / LAG - 3 triple — CD4 + T cells, ( D) 1. 18 - fold - change in integrated HIV DNA for 1 point increase in percentage of PD - 1 / TIGIT double + CD4 + T cells, ( E) 1. 30 - fold - change in integrated HIV DNA for 1 point increase in percentage of TIGIT / LAG - 3 double + CD4 + T cells and ( F) 1. 94 - fold - change in integrated HIV DNA for 1 point increase in percentage of PD - 1 / TIGIT / LAG - 3 triple + CD4 + T cells.	"HIV	91	94	Organism/Species"	"PD - 1	137	143	Gene/Protein"	"TIGIT	146	151	Gene/Protein"	"LAG - 3	154	161	Gene/Protein"	"CD4	171	174	Gene/Protein"	"HIV	227	230	Organism/Species"	"PD - 1	273	279	Gene/Protein"	"TIGIT	282	287	Gene/Protein"	"CD4	297	300	Gene/Protein"	"HIV	353	356	Organism/Species"	"TIGIT	399	404	Gene/Protein"	"LAG - 3	407	414	Gene/Protein"	"CD4	424	427	Gene/Protein"	"HIV	483	486	Organism/Species"	"PD - 1	529	535	Gene/Protein"	"TIGIT	538	543	Gene/Protein"	"LAG - 3	546	553	Gene/Protein"	"CD4	563	566	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 273, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 282, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 297, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 353, ""end_span"": 356, ""type"": ""Organism/Species""}, {""token"": ""TIGIT"", ""start_span"": 399, ""end_span"": 404, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 407, ""end_span"": 414, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 424, ""end_span"": 427, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 483, ""end_span"": 486, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 529, ""end_span"": 535, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 538, ""end_span"": 543, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 546, ""end_span"": 553, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 563, ""end_span"": 566, ""type"": ""Gene/Protein""}]"
When the negative binomial regression model was used to assess the relationship between Total HIV DNA, 2 - LTR circles, CA - US RNA and the frequency of CD4 + T cells expressing PD - 1 and / or TIGIT and / or LAG - 3, no association show statistically significant, with the exception of the frequency of CD4 + T cells harboring total HIV DNA and the frequency of PD - 1 single + ( p = 0. 005, 1. 10 - fold - change in total HIV DNA for 1 point increase in percentage of PD - 1 single + CD4 + T cells) and PD - 1 / TIGIT double + CD4 + T cells ( p = 0. 017, 1. 40 - fold - change in total HIV DNA for 1 point increase in percentage of PD - 1 / TIGIT double + CD4 + T cells ).	"HIV	94	97	Organism/Species"	"CD4	153	156	Gene/Protein"	"PD - 1	178	184	Gene/Protein"	"TIGIT	194	199	Gene/Protein"	"LAG - 3	209	216	Gene/Protein"	"CD4	304	307	Gene/Protein"	"HIV	334	337	Organism/Species"	"PD - 1	363	369	Gene/Protein"	"HIV	424	427	Organism/Species"	"PD - 1	470	476	Gene/Protein"	"CD4	486	489	Gene/Protein"	"PD - 1	505	511	Gene/Protein"	"TIGIT	514	519	Gene/Protein"	"CD4	529	532	Gene/Protein"	"HIV	588	591	Organism/Species"	"PD - 1	634	640	Gene/Protein"	"TIGIT	643	648	Gene/Protein"	"CD4	658	661	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 304, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 334, ""end_span"": 337, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 363, ""end_span"": 369, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 424, ""end_span"": 427, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 470, ""end_span"": 476, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 486, ""end_span"": 489, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 505, ""end_span"": 511, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 514, ""end_span"": 519, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 529, ""end_span"": 532, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 588, ""end_span"": 591, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 634, ""end_span"": 640, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 643, ""end_span"": 648, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 658, ""end_span"": 661, ""type"": ""Gene/Protein""}]"
